Sfoglia per Autore
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen
2009-01-01 Vignani F; Russo L; Tucci M; Motta M; Vellani G; Tampellini M; Papotti M; Dogliotti L; Berruti A.
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.
2010-01-01 Berruti A;Vignani F;Russo L;Bertaglia V;Tullio M;Tucci M;Poggio M;Dogliotti L
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone.
2013-01-01 Pia, Anna; Vignani, Francesca; Attard, Gerhardt; Tucci, Marcello; Bironzo, Paolo; Scagliotti, Giorgio; Arlt, Wiebke; Terzolo, Massimo; Berruti, Alfredo*
Metastatic castration-resistant prostate cancer: Time for innovation
2015-01-01 Tucci, Marcello; Scagliotti, Giorgio Vittorio; Vignani, Francesca
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
2015-01-01 Iuliani, Michele; Pantano, Francesco; Buttigliero, Consuelo; Fioramonti, Marco; Bertaglia, Valentina; Vincenzi, Bruno; Zoccoli, Alice; Ribelli, Giulia; Tucci, Marcello; Vignani, Francesca; Berruti, Alfredo; Scagliotti, Giorgio Vittorio; Tonini, Giuseppe; Santini, Daniele
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome
2015-01-01 Buttigliero, Consuelo; Vana, Federica; Bertaglia, Valentina; Vignani, Francesca; Fiori, Cristian; Osella, Giangiacomo; Porpiglia, Francesco; Tucci, Marcello; Scagliotti, Giorgio Vittorio; Berruti, Alfredo
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer
2015-01-01 Buttigliero, Consuelo; Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio Vittorio
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer
2016-01-01 Vignani, Francesca; Bertaglia, Valentina; Buttigliero, Consuelo; Tucci, Marcello; Scagliotti, Giorgio V.; Di Maio, Massimo
Rediscovering secondary tumors of the prostate in the molecular era
2016-01-01 Fusco, Nicola; Sciarra, Amedeo; Guerini-Rocco, Elena; Marchiò, Caterina; Vignani, Francesca; Colombo, Piergiuseppe; Ferrero, Stefano
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
2016-01-01 Lo Iacono, Marco; Buttigliero, Consuelo; Monica, Valentina; Bollito, Enrico; Garrou, Diletta; Cappia, Susanna; Rapa, Ida; Vignani, Francesca; Bertaglia, Valentina; Fiori, Cristian; Papotti, Mauro; Volante, Marco; Scagliotti, Giorgio V.; Porpiglia, Francesco; Tucci, Marcello
Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis
2016-01-01 Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Buttigliero, Consuelo; Fiori, Cristian; Porpiglia, Francesco; Scagliotti, Giorgio Vittorio; Di Maio, Massimo
C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis
2016-01-01 Tucci, M.; Buttigliero, C.; Vignani, F.; Iaconis, D.; Bertaglia, V.; Bironzo, P.; Pignataro, D.; Scagliotti, G.V.; Di Maio, M.
Immunotherapy for patients with advanced urothelial cancer: Current evidence and future perspectives
2017-01-01 Zichi, Clizia; Tucci, Marcello; Leone, Gianmarco; Buttigliero, Consuelo; Vignani, Francesca; Pignataro, Daniele; Scagliotti, Giorgio V.; Di Maio, Massimo
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer
2017-01-01 Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Scagliotti, Giorgio V; Di Maio, Massimo
Immediate or delayed nephrectomy in patients with metastatic renal cancer who are receiving targeted agents: Is the analysis at risk for guarantee- time bias?
2017-01-01 Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Di Maio, Massimo
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer
2017-01-01 Bertaglia, Valentina; Tucci, Marcello*; Vignani, Francesca; Buttigliero, Consuelo; Aroasio, Emiliano; Berruti, Alfredo; Scagliotti, Giorgio V.; Di Maio, Massimo
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel
2017-01-01 Buttigliero, Consuelo; Pisano, Chiara; Tucci, Marcello; Vignani, Francesca; Bertaglia, Valentina; Iaconis, Davide; Guglielmini, Pamela; Numico, Gianmauro; Scagliotti, Giorgio V.; Di Maio, Massimo
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel
2018-01-01 Buttigliero, Consuelo; Tucci, Marcello*; Vignani, Francesca; Di Stefano, Rosario F.; Leone, Gianmarco; Zichi, Clizia; Pignataro, Daniele; Lacidogna, Gaetano; Guglielmini, Pamela; Numico, Gianmauro; Scagliotti, Giorgio V.; Di Maio, Massimo
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis
2018-01-01 Di Nunno, Vincenzo; De Luca, Emmanuele; Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Gatto, Lidia; Zichi, Clizia; Ardizzoni, Andrea; Di Maio, Massimo; Massari, Francesco*
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis
2018-01-01 Di Maio, Massimo; Baratelli, Chiara; Bironzo, Paolo; Vignani, Francesca; Bria, Emilio; Sperti, Elisa; Marcato, Maddalena; Roila, Fausto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen | 2009 | Vignani F; Russo L; Tucci M; Motta M; Vellani G; Tampellini M; Papotti M; Dogliotti L; Berruti A. | |
| Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. | 2010 | Berruti A;Vignani F;Russo L;Bertaglia V;Tullio M;Tucci M;Poggio M;Dogliotti L | |
| Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. | 2013 | Pia, Anna; Vignani, Francesca; Attard, Gerhardt; Tucci, Marcello; Bironzo, Paolo; Scagliotti, Giorgio; Arlt, Wiebke; Terzolo, Massimo; Berruti, Alfredo* | |
| Metastatic castration-resistant prostate cancer: Time for innovation | 2015 | Tucci, Marcello; Scagliotti, Giorgio Vittorio; Vignani, Francesca | |
| Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment | 2015 | Iuliani, Michele; Pantano, Francesco; Buttigliero, Consuelo; Fioramonti, Marco; Bertaglia, Valentina; Vincenzi, Bruno; Zoccoli, Alice; Ribelli, Giulia; Tucci, Marcello; Vignani, Francesca; Berruti, Alfredo; Scagliotti, Giorgio Vittorio; Tonini, Giuseppe; Santini, Daniele | |
| The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome | 2015 | Buttigliero, Consuelo; Vana, Federica; Bertaglia, Valentina; Vignani, Francesca; Fiori, Cristian; Osella, Giangiacomo; Porpiglia, Francesco; Tucci, Marcello; Scagliotti, Giorgio Vittorio; Berruti, Alfredo | |
| Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer | 2015 | Buttigliero, Consuelo; Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio Vittorio | |
| Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer | 2016 | Vignani, Francesca; Bertaglia, Valentina; Buttigliero, Consuelo; Tucci, Marcello; Scagliotti, Giorgio V.; Di Maio, Massimo | |
| Rediscovering secondary tumors of the prostate in the molecular era | 2016 | Fusco, Nicola; Sciarra, Amedeo; Guerini-Rocco, Elena; Marchiò, Caterina; Vignani, Francesca; Colombo, Piergiuseppe; Ferrero, Stefano | |
| Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer | 2016 | Lo Iacono, Marco; Buttigliero, Consuelo; Monica, Valentina; Bollito, Enrico; Garrou, Diletta; Cappia, Susanna; Rapa, Ida; Vignani, Francesca; Bertaglia, Valentina; Fiori, Cristian; Papotti, Mauro; Volante, Marco; Scagliotti, Giorgio V.; Porpiglia, Francesco; Tucci, Marcello | |
| Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis | 2016 | Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Buttigliero, Consuelo; Fiori, Cristian; Porpiglia, Francesco; Scagliotti, Giorgio Vittorio; Di Maio, Massimo | |
| C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis | 2016 | Tucci, M.; Buttigliero, C.; Vignani, F.; Iaconis, D.; Bertaglia, V.; Bironzo, P.; Pignataro, D.; Scagliotti, G.V.; Di Maio, M. | |
| Immunotherapy for patients with advanced urothelial cancer: Current evidence and future perspectives | 2017 | Zichi, Clizia; Tucci, Marcello; Leone, Gianmarco; Buttigliero, Consuelo; Vignani, Francesca; Pignataro, Daniele; Scagliotti, Giorgio V.; Di Maio, Massimo | |
| Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer | 2017 | Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Scagliotti, Giorgio V; Di Maio, Massimo | |
| Immediate or delayed nephrectomy in patients with metastatic renal cancer who are receiving targeted agents: Is the analysis at risk for guarantee- time bias? | 2017 | Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Di Maio, Massimo | |
| An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer | 2017 | Bertaglia, Valentina; Tucci, Marcello*; Vignani, Francesca; Buttigliero, Consuelo; Aroasio, Emiliano; Berruti, Alfredo; Scagliotti, Giorgio V.; Di Maio, Massimo | |
| Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel | 2017 | Buttigliero, Consuelo; Pisano, Chiara; Tucci, Marcello; Vignani, Francesca; Bertaglia, Valentina; Iaconis, Davide; Guglielmini, Pamela; Numico, Gianmauro; Scagliotti, Giorgio V.; Di Maio, Massimo | |
| Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel | 2018 | Buttigliero, Consuelo; Tucci, Marcello*; Vignani, Francesca; Di Stefano, Rosario F.; Leone, Gianmarco; Zichi, Clizia; Pignataro, Daniele; Lacidogna, Gaetano; Guglielmini, Pamela; Numico, Gianmauro; Scagliotti, Giorgio V.; Di Maio, Massimo | |
| Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis | 2018 | Di Nunno, Vincenzo; De Luca, Emmanuele; Buttigliero, Consuelo; Tucci, Marcello; Vignani, Francesca; Gatto, Lidia; Zichi, Clizia; Ardizzoni, Andrea; Di Maio, Massimo; Massari, Francesco* | |
| Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis | 2018 | Di Maio, Massimo; Baratelli, Chiara; Bironzo, Paolo; Vignani, Francesca; Bria, Emilio; Sperti, Elisa; Marcato, Maddalena; Roila, Fausto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile